Company / R&D per Share
Immuneering Corp R&D per Share History
FY2021-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.37
FY2023
5-year range
$1.37 / $3.03
FY2021-FY2023
Trend
-29.5%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $3.03 to $1.37 over the past 2 years.
Based on SEC 10-K filings.
1.37 in FY2023.
Declined from $3.03 to $1.37 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, r&d per share decreased 29.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -7.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $1.37 | -29.5% |
| FY2022 | $1.95 | -35.7% |
| FY2021 | $3.03 | - |
As of FY2023 · SEC 10-K · Updated Jun 24, 2026